Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 1
1994 1
1995 2
1996 1
1998 1
1999 3
2000 1
2001 1
2002 4
2003 3
2004 2
2005 1
2006 2
2007 2
2008 7
2009 7
2010 2
2011 1
2012 1
2013 2
2014 3
2015 5
2016 4
2017 3
2018 5
2019 4
2021 2
2022 1
2023 2
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Soft Tissue Disorders of the Mouth.
Diebold S, Overbeck M. Diebold S, et al. Emerg Med Clin North Am. 2019 Feb;37(1):55-68. doi: 10.1016/j.emc.2018.09.006. Emerg Med Clin North Am. 2019. PMID: 30454780 Review.
Innate recognition of viruses.
Diebold S. Diebold S. Immunol Lett. 2010 Jan 18;128(1):17-20. doi: 10.1016/j.imlet.2009.09.010. Epub 2009 Oct 4. Immunol Lett. 2010. PMID: 19808054 Review.
Regulation of dendritic cell function by microbial stimuli.
Reis e Sousa C, Diebold SD, Edwards AD, Rogers N, Schulz O, Spörri R. Reis e Sousa C, et al. Among authors: diebold sd. Pathol Biol (Paris). 2003 Mar;51(2):67-8. doi: 10.1016/s0369-8114(03)00099-3. Pathol Biol (Paris). 2003. PMID: 12801803 Review.
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies).
Tounekti O, Prior S, Wassmer S, Xu J, Wong A, Fang X, Sonderegger I, Smeraglia J, Huleatt J, Loo L, Beaver C, DelCarpini J, Dessy F, Diebold S, Fiscella M, Garofolo F, Grimaldi C, Gupta S, Hou V, Irwin C, Jani D, Joseph J, Kalina W, Kar S, Kavita U, Lu Y, Marshall JC, Mayer C, Mora J, Nolan K, Peng K, Riccitelli N, Scully I, Seitzer J, Stern M, Wadhwa M, Xu Y, Verthelyi D, Sumner G, Clements-Egan A, Chen C, Gorovits B, Torri A, Baltrukonis D, Gunn G, Ishii-Watabe A, Kramer D, Kubiak RJ, Mullins G, Pan L, Partridge MA, Poetzl J, Rasamoelisolo M, Sirtori FR, Richards S, Saad OM, Shao W, Song Y, Song S, Staack RF, Wu B, Manangeeswaran M, Thacker S. Tounekti O, et al. Among authors: diebold s. Bioanalysis. 2025 Feb;17(3):105-149. doi: 10.1080/17576180.2024.2439229. Epub 2025 Jan 25. Bioanalysis. 2025. PMID: 39862111
74 results